Open an account

Strive

ASST · NASDAQ

$27.06+$1.52 (+5.95%)TodayMarket closed ·
Prev close $25.54

About ASST

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. The company is headquartered in Dallas, Texas and currently employs 28 full-time employees. The company went IPO on 2023-02-03. The firm is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The firm's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Employees
28
Headquarters
Dallas, Texas
Listed
Feb 3, 2023
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
investors.strive.com

ASST key statistics

Market cap
2.75B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
8.84M
Volume
8.48M
Open price
$25.00
High today
$27.46
Low today
$24.93
52 Week high
$36.20
52 Week low
$7.02

Strive (ASST) at a glance

Strive (ASST) last traded at $27.06, with a market cap of 2.75B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $24.93 and $27.46. The current price is 8.6% above the day's low and 1.5% below its high.

Volume so far is 8.48M shares, in line with the average of 8.84M shares a day.

Over the past year Strive has ranged from $7.02 to $36.20, and now sits 69% of the way up that range.

Strive met or beat analyst EPS estimates in 0 of the last 2 quarters. In Q2 FY26 it reported -$3.65 per share against an estimate of $1.59.

The average analyst price target is $33.86, 25.1% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 5 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 7 analystsAvg $33.86
Low
$21.21
Now
$27.06
High
$46.20

ASST earnings

Earnings per share, reported against the analyst estimate

Didn’t beat the estimate in any of the last 2 quarters.

  1. Q1 FY26: reported -$5.19 per share against an estimate of -$2.62
  2. Q2 FY26: reported -$3.65 per share against an estimate of $1.59

ASST news

  • Khyathi Dalal

    Could Bitcoin's Next Big Catalyst Come From the $300 Trillion Bond Market?

  • Parshwa Turakhiya

    Looking Beyond Bitcoin? Analysts See Bigger Opportunities in These 5 Altcoins

  • Chandrima Sanyal

    Wall Street's ETF Factory Is Going Wild: 3X Bets, AI Fever and 1,100 New Funds

  • Crispus Nyaga

    Top 4 Crypto Stocks to Watch This Week: BitMine, Strategy, Strive, BitGo

  • Khyathi Dalal

    Will Bitcoin Hit $500,000 by 2030? Strive CEO Matt Cole Says Maybe

  • Khyathi Dalal

    TD Cowen: Bitcoin to Hit $132,750 by 2028, Strategy, Strive Could Outperform

  • Parshwa Turakhiya

    Strategy Buys 334 Bitcoin but Strive Bought 2,000: What's Going On?

  • Aniket Verma

    Vivek Ramaswamy-Founded Strive to Acquire More Bitcoin? Here's What the CEO Hinted at

Similar companies

Companies in the same industry as Strive

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.